GNFT(Delisted)
GenfitยทNASDAQ
--
--(--)
GNFT Profile
Genfit S.A.
A late-stage biopharmaceutical company that develops therapeutic diagnostic solutions for metabolic liver-related diseases
Parc Eurasante, 885, avenue Eugene Avinee, 59120 Loos, France
--
Genfit S.A. is a late-stage clinical biopharmaceutical company dedicated to the discovery and development of innovative drug candidates and diagnostic solutions for metabolic and liver-related diseases, where there are considerable unmet medical needs. They are leaders in nuclear receptor-based drug discovery with a rich history of nearly 20 years and a strong scientific legacy.
